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e wish to call the readership’s attention to the recent study by
oonstra et al. [1] on the systematic review that showed that the
ncidence and the prevalence of primary sclerosing cholangitis
nd primary biliary cirrhosis vary widely based on the geograph
cal distribution. Further, it was previously observed that the
everity and the incidence of primary sclerosing cholangitis were
nﬂuenced by ethnicity [2,3]. We expanded here the scope of this
ethodology to another biliary disease, i.e. biliary atresia (BA)
hich is a destructive cholangiopathy of neonates that leads to
iliary cirrhosis. Furthermore, it constitutes a public health issue
s being the main reason for liver transplantation in children.
Incidence of BA differs between studies. We hypothesized
hat the incidence of this disease could also be inﬂuenced by
thnicity. We thus conducted a systematic literature search to
dentify articles containing information on the incidence of bil
ary atresia according to ethnicity. Keywords for the database
earch of MEDLINE (1840 to January 2012) were ‘‘biliary atresia’
nd ‘‘incidence’’, which were further cross-linked with eithe
‘ethnic’’ or ‘‘ethnicity’’ or ‘‘racial’’ for the search in Google Scho
ar (Biology and Medicine only). Of 660 references, 96 appeared
o contain information related to the topic of interest. Refer
nces were included in this review if all of the following items
ere present: time period and location of the study, total live
irths and number of infants with biliary atresia according to
thnic origin. Incidences of BA were retrieved from the included
eferences, and were plotted on a world map (Fig. 1), which
ndicates the highest incidence in French Polynesia. We thus
ombined a population-based observation, and studied the inci
ence of BA over a time period of 30 years (1979–2009) in Poly
esians and Caucasians living in French Polynesia. We found
hat the incidence of BA at 33.5 per 100,000 live births in Polyisher exact test) (Fig. 1). From the systematic review, we
xtracted six other studies [4–9] that reported incidence accord-
g to the ethnic origin of the patients. Incidence was high in
olynesians [4,5,10] and native Indians/Inuits [5], intermediate
Asians [6], and low in Caucasians [5,7–9] (Fig. 1). Three of
e six studies enabled calculation of the incidence in people
f different ethnic origins who share the same geographic loca-
on. We found that the incidence of BA was signiﬁcantly differ-
nt between Caucasians and Polynesian Maoris in New Zealand
], Caucasians and native Indians/Inuits in Canada [5], and Cau-
sians and African-Americans in the United States of America
] with p-values of 10-7, 10-5 and 0.013, respectively (Chi-
uare test results). Thus, our previous ﬁnding that BA was sea-
nal in French Polynesia [10] suggests that the interplay
etween ancestry and environment determines the predisposi-
on of Polynesians to BA. As pointed out by Boonstra et al.
], epidemiological data may help identify etiological factors
r these complex diseases. Because most epidemiological stud-
s are performed in mixed populations, we propose that future
udies on BA and primary sclerosing cholangitis take into
ccount the ethnicity.
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Fig. 1. Worldwide disparities of the incidence of biliary atresia according to ethnicity. Incidences of BA were retrieved from the included references, and were plotted
on a world map centralized on the Paciﬁc Ocean (d-maps.com). Incidences are indicated per 100,000 live births within the geometric forms, which schematize the different
ethnic groups. Triangles, diamonds, pentagon, square and round account for Caucasians, Polynesians, Asians, African-Americans, and native Indians/Inuits, respectively.
Differences among the incidences in people of different ethnic origin who share the same geographic location were statistically assessed, as shown above the brackets.
#Canadian statistics (www.statscan.gc.ca) ⁄New-Zealand statistics (www.stats.govt.nz).
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